Abstract: The field of neurodegeneration research has long been focused on finding therapeutic strategies to effectively decrease or halt neuronal loss while minimizing side effects. A recent study titled “Inhibiting acute, axonal DLK palmitoylation is neuroprotective and avoids deleterious effects of cell-wide DLK inhibition”(Zhang et al., 2025), describes an innovative approach to achieve this goal. The authors target a specific posttranslational modification of dual leucine-zipper kinase (DLK), palmitoylation, to selectively inhibit DLK-dependent pro-degenerative signaling and protect neurons, thereby revealing a new way to intervene and block neurodegeneration. This Perspective aims to explore the significance of these findings and propose directions for future research.